TLIS

TALIS BIOMEDICAL CORP

1 day chart

About TLIS

Talis Biomedical Corporation is engaged in transforming diagnostic testing by developing and commercializing products that are designed to enable molecular testing for infectious diseases and other conditions at the point of care. The Company is engaged in developing the Talis One system, a cloud-enabled molecular diagnostic platform. The Talis One system consists of compact instrument, single-use test cartridges and software that is designed to support a central cloud database, which work together and are designed to provide central laboratory levels of accuracy and be operated by an untrained user. It is also focused on developing Talis One assay kits for respiratory infections, and infections related to women's health and sexually transmitted infections (STIs). It is also developing influenza A and influenza B tests to be included as part of a respiratory panel with its COVID-19 assay (Respiratory Panel), as well as exploring adding a respiratory syncytial virus (RSV) test.

Buy US stocks in Australia starting with TLIS. Open an account and start investing today!

Market Capitalisation

$11.30M

Price-earnings ratio

Dividend yield

0.00%

Volume

24.35K

High today

$6.25

Low today

$5.79

Open price

$6.01

52-week high

$14.25

52-week low

$5.80

TLIS FAQs

Can I buy TLIS shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?

Yes, the Stake platform allows you to buy TLIS shares and over 8,000 stocks and ETFs across the ASX and Wall St.

How much is one share of TALIS BIOMEDICAL CORP?

One share of TALIS BIOMEDICAL CORP is valued at $6.81.

What is the ticker symbol for TALIS BIOMEDICAL CORP?

The ticker symbol for TALIS BIOMEDICAL CORP is TLIS.

How do I buy TLIS shares in Australia?

To buy TLIS stocks in Australia you'll need to open an account with an investing platform like Stake.
To do so follow these steps:

Sign up in minutes, all you need is some I.D.
Choose Stake Wall St
Deposit directly into your Stake wallet and you're ready to invest in TLIS

What is the 52-week high for TALIS BIOMEDICAL CORP stock?

The TALIS BIOMEDICAL CORP 52-week high stock price is $14.25.

What is the 52-week low for TALIS BIOMEDICAL CORP stock?

The TALIS BIOMEDICAL CORP 52-week low stock price is $5.80.

What is the market capitalisation of TALIS BIOMEDICAL CORP TLIS?

As of 16/09/2023 TALIS BIOMEDICAL CORP has a market cap of $11M.

Related Stocks

This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.